1Saif MW, Makrilia N, ZalonisA, et ed. Gastric cancer in the elderly: an overview[J]. Eur J Sur Oncol, 2010, 36(8): 709-717.
2Mizukami T, Togashi Y, Sogabe S, et al. EGFR and HER2 signals play a salvage role in MEKl-mutated? gastric cancer? after MEK inhibition [J]. Int J Oncol, ? 2015, 47 (2): 499-505.
3Park do J, Thomas NJ, Yoon C, et al. Vascular endothelial growth factor a inhibition in gastric cancer [J]. Gastric Cancer, 2015, 18 (1): 33-42.
10Radovanovi D, Knezevi M, Canovi D, et al. Correlation between p53 expression and clinical-pathological characteristics ofgastriccancel"[J].VojnosanitPregl,2011,68(1o):832-836.
8Okabayashi T, Kobayashi M, Nishimori I, et al. Clinicopathological features and medical management of early gastric cancer [J]. Am J Surg, 2008,195(2):229-232.
9Wang X, Wan F, Pan J, et al. Tumor size: a non-neglect able independent prognostic factor for gastric cancer [J]. J Surg Onto1, 2008,97(3): 236-240.
10Surveillance Epidemiology and End Results (SEER) Program. SEER ^*Stat Database: Incidence -SEER 9 Regs Public-Use, 2007, Sub (1975-2005), National Cancer Institute, DCCPS, Surveillance Research Program, based on the 2007 submission. National Cancer Institute serial online, 2008-04, cited 2008-05; 1(1): 24 screens. Available from: http://seer.cancer. gov/faststats/selections.php#Output